Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Longbio Pharma logo — A biotech to R&D innovative antibody/protein drugs of allerg...

Longbio Pharma

A biotech to R&D innovative antibody/protein drugs of allergic and complement diseases.

Founded 2020 2 employees Series B Total: $100.00M Biotechnology, Pharmaceutical

General Information

Company Name Longbio Pharma
Founded Year 2020
Employees 2
Industries Biotechnology, Pharmaceutical
Funding Stage Series B
Social

Get notified when Longbio Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Longbio Pharma

Longbio Pharma is a biotech startup founded in 2018, based in Zhangjiang Hi-tech Park, Shanghai. With a team of 40+ scientists boasting over 10 years of experience in developing protein drugs, including antibodies and fusion proteins, Longbio Pharma has already achieved significant success. The co-founder team has a track record of successfully bringing two drugs to market, with accumulated global sales reaching USD 30 billion. Currently, the company is focused on R&D for innovative drugs targeting autoimmune and rare diseases, specifically in the areas of allergy and complement. In October 2023, Longbio Pharma secured a Series B investment of CNY 100.00 million from a consortium of investors including Oriental Fortune Capital, Shanxi Securities Investment, Huzhou Youcheng, Hefei Hongda, and Changshu Wuyue Angel Venture Capital. This recent injection of funding reflects growing confidence in the potential of Longbio Pharma's innovative approach to treating challenging medical conditions, positioning the company for further breakthroughs in the biotechnology and pharmaceutical industries.

Taxonomy: Biotech, R&D, Antibody drugs, Protein drugs, Allergic diseases, Complement diseases, Drug development, Autoimmune diseases, Rare diseases, Shanghai, Zhangjiang Hi-tech Park, Scientist team, Co-founder team, Innovation, Pharma

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 5
Investor Investor
•••• •••• 		31 Oct 2023

Longbio Pharma Alternatives & Competitors

Longbio Pharma vs
Laminar Pharma
Laminar Pharma Spain

Biopharmaceutical company performing discovery, rational design and initial clinical development of...

Unknown
39 employees
Biotechnology, Life Sciences
Longbio Pharma vs
EUROMED PHARMA FRANCE
EUROMED PHARMA FRANCE France

Pharmaceutical tailor-made solutions

11 employees
Longbio Pharma vs
INVENT Pharmaceuticals
INVENT Pharmaceuticals United States

Transforming molecules to medicines

1 employees
Biotechnology, Health Care

FAQ About Longbio Pharma

A biotech to R&D innovative antibody/protein drugs of allergic and complement diseases.
Longbio Pharma was founded in 2020.
Longbio Pharma operates in the following industries: Biotechnology, Pharmaceutical.
Longbio Pharma has approximately 2 employees.
Longbio Pharma has completed 1 funding round, raising a total of $100.00M. The latest funding stage is Series B.
Top alternatives and competitors to Longbio Pharma include Laminar Pharma, EUROMED PHARMA FRANCE, INVENT Pharmaceuticals, Forward Pharma, Biosun Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Longbio Pharma and Laminar Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Longbio Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy